|
Market Closed -
Nasdaq
00:00:00 17/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 62.23 USD | -0.95% |
|
+3.96% | +41.98% |
| 10-09 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| 10-09 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
Chart calendar Exelixis, Inc.
Upcoming events on Exelixis, Inc.
| 30/10/2026 | Earnings presentation | 01:00 |
| 30/10/2026 | Earnings release - Q3 2026 |
Past events on Exelixis, Inc.
| 06/08/2026 | Earnings presentation | 01:00 |
| 06/08/2026 | Earnings release - Q2 2026 | |
| 26/05/2026 | Présentation aux Actionnaires / Analystes | 20:00 |
| 26/05/2026 | Annual General Meeting | 20:00 |
| 06/05/2026 | Earnings release - Q1 2026 | |
| 06/05/2026 | Earnings presentation | 01:00 |
| 11/02/2026 | Earnings presentation | 02:00 |
| 11/02/2026 | Earnings release - Q4 2025 | |
| 10/12/2025 | Information meeting | 22:00 |
| 05/11/2025 | Earnings presentation | 02:00 |
| 05/11/2025 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 830 1 829 0.06% | 2 169 2 164 0.2% | 2 320 2 320 0.01% | 2 554 | 2 902 | 3 315 |
|
EBITDA Million USD | Released Forecast Spread | 197 215 -8.7% | 633 657 -3.65% | 901 955 -5.67% | 1 091 | 1 279 | 1 595 |
|
EBIT Million USD | Released Forecast Spread | 171 184 -7.18% | 605 595 1.62% | 872 863 1.11% | 1 031 | 1 286 | 1 576 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 258 252 2.39% | 682 670 1.76% | 941 935 0.66% | 1 057 | 1 349 | 1 669 |
|
Net income Million USD | Released Forecast Spread | 208 199 4.36% | 521 514 1.36% | 783 742 5.42% | 820 | 1 002 | 1 258 |
|
EPS USD | Released Forecast Spread | 0,65 0,61 6.85% | 1,76 1,73 1.71% | 2,78 2,65 4.89% | 3,23 | 3,92 | 5,19 |
| Announcement Date | 06/02/24 | 11/02/25 | 10/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 567 563 0.63% | 555 501 10.88% | 568 580 -2.01% | 598 590 1.28% | 599 601 -0.39% | 611 605 0.98% | 629 636 -1.17% | 650 | 664 | 674 | 704 | 729 | 760 |
|
EBITDA Million USD | Released Forecast Spread | 171 158 8.1% | 244 167 46.44% | 242 250 -3.23% | 258 216 19.59% | 255 254 0.52% | 264 | 277 | 273 | 297 | ||||
|
EBIT Million USD | Released Forecast Spread | 163 141 15.83% | 187 111 68.53% | 214 193 10.78% | 237 201 17.9% | 235 220 6.69% | 251 223 12.85% | 248 256 -2.91% | 256 | 257 | 262 | 297 | 304 | 314 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 185 158 16.83% | 206 130 58.26% | 230 211 9.27% | 252 221 13.96% | 253 237 6.53% | 268 241 10.92% | 263 263 -0.21% | 269 | 261 | 290 | 313 | 315 | 277 |
|
Net income Million USD | Released Forecast Spread | 140 108 29.34% | 160 108 48.16% | 185 162 14.01% | 194 168 15.19% | 245 205 19.5% | 210 188 11.75% | 212 202 4.82% | 205 | 202 | 227 | 246 | 247 | 217 |
|
EPS USD | Released Forecast Spread | 0,48 0,43 12.85% | 0,55 0,36 51.49% | 0,65 0,56 16.43% | 0,69 0,61 13.57% | 0,88 0,75 17.84% | 0,79 0,70 12.29% | 0,82 0,79 4.45% | 0,82 | 0,84 | 0,88 | 0,97 | 1,03 | 0,98 |
| Announcement Date | 11/02/25 | 13/05/25 | 28/07/25 | 04/11/25 | 10/02/26 | 05/05/26 | 05/08/26 | - | - | - | - | - | - |
| 21/10/2026 |  | Information meeting | 17:00 |
| 22/10/2026 | | Earnings release - Q3 2026 | |
| 22/10/2026 | | Earnings presentation | 16:30 |
| 23/10/2026 | | Extraordinary General Meeting | 10:00 |
| 26/10/2026 | | Earnings release - Q3 2026 | |
| 26/10/2026 | | Board of Directors Meeting | |
| 26/10/2026 | | Earnings release - Q3 2026 | |
| 26/10/2026 | | Board of Directors Meeting | |
| 27/10/2026 | | Information meeting | 16:00 |
| 27/10/2026 | | Information meeting | 22:00 |
Past sector events for Exelixis, Inc.
| 15/10/2026 | | Présentation aux Actionnaires / Analystes | |
| 15/10/2026 | | Sales and Revenue Release - Q3 2026 | |
| 14/10/2026 | | Information meeting | 22:30 |
| 14/10/2026 | | Présentation aux Actionnaires / Analystes | |
| 14/10/2026 | | Information meeting | 00:30 |
| 14/10/2026 | | Extraordinary General Meeting | 06:00 |
| 14/10/2026 | | Information meeting | 16:00 |
| 07/10/2026 | | Extraordinary General Meeting | 17:00 |
| 07/10/2026 | | Présentation aux Actionnaires / Analystes | 17:00 |
| 06/10/2026 | | Information meeting | 18:00 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- EXEL Stock
- Calendar Exelixis, Inc.
Select your edition
All financial news and data tailored to specific country editions
